Protein tyrosine phosphatase receptor gamma (PTPRG) expression is a natural inhibitory mechanism that is downregulated in chronic myeloid leukemia (CML) disease. Here, PTPRG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.